Which of these was your favorite Super Bowl commercial?
We thought we’d take a break from serious healthcare topics this week and ask a just-for-fun question about Super Bowl ad preferences. We saw Pfizer's "Here's To Science." but as far as we know, no other healthcare companies advertised during last night’s game, which the Kansas City Chiefs won in overtime, much to the delight of a certain singer and her boyfriend. For lack of a big showing by healthcare companies, we selected some advertisers that are somewhat health and healthcare adjacent. And we added a couple of our favorites (those E*Trade babies get us every time).
What was your favorite Superbowl commercial?
We want to know what you’re thinking! Every Monday morning, the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. We'll tally your answers and publish the results on Friday by 4 p.m. ET.
Have a suggestion for a Question for the Week? Please send it to Peter Wehrwein at pwehrwein@mjhlifesciences.com
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
AI Benefits PBMs, Health Plans and Formulary Decision Making | AMCP Nexus 2024
October 21st 2024Health plans and PBMs are using AI to aggregate data, summarize information and enhance their formulary decision-making processes, according to Douglas S. Burgoyne, Pharm.D., MBA, FAMCP, adjunct associate professor at the University of Utah College of Pharmacy.
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024
Published: October 21st 2024 | Updated: October 21st 2024Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy complications in patients. But this could be an early worsening of disease unrelated to treatment.
Read More